1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infant, Newborn, Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Infant, Newborn, Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bi, MZ; Gao, Z; Liu, XH; Pei, LN; Zhang, H; Zhu, J	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Infant, Newborn, Diseases

Article	Year
Clinical efficacy of mouse nerve growth factor plus nimodipine in neonatal intracranial hemorrhage and its effect on plasma PAF, CNP, MMP-2, and neurological function. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:1 Topics: Animals; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Intracranial Hemorrhages; Matrix Metalloproteinase 2; Mice; Natriuretic Peptide, C-Type; Nerve Growth Factor; Nimodipine; Platelet Activating Factor; Retrospective Studies	2021

Article

Year

Clinical efficacy of mouse nerve growth factor plus nimodipine in neonatal intracranial hemorrhage and its effect on plasma PAF, CNP, MMP-2, and neurological function.

European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:1

Topics: Animals; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intramuscular; Intracranial Hemorrhages; Matrix Metalloproteinase 2; Mice; Natriuretic Peptide, C-Type; Nerve Growth Factor; Nimodipine; Platelet Activating Factor; Retrospective Studies

2021